Location History:
- Boxmeer, NL (2013 - 2015)
- Oss, NL (2015)
Company Filing History:
Years Active: 2013-2015
Title: Hans Almer Middelbeek: Innovative Inventor Shaping the Pharmaceutical Industry
Introduction:
In the world of pharmaceuticals, innovation plays a crucial role in improving drug delivery systems and patient experiences. Hans Almer Middelbeek, a seasoned inventor based in Boxmeer, NL, has made significant contributions to the field with his pioneering patents and inventions. This article explores his latest patents, career highlights, collaborations, and the impact of his work on the pharmaceutical industry.
Latest Patents:
Hans Almer Middelbeek is credited with five patents to his name, showcasing his expertise and commitment to advancing pharmaceutical technology. Two of his recent patents have revolutionized the formulation and administration of medicinal substances in tablet form.
The first patent, titled "Process to Form a Tablet and Apparatus Suitable for Applying this Process," describes a process for preparing a fast-disintegrating tablet. This innovative approach involves filling a cavity in a solid element with a fluid formulation of the medicinal substance and subsequently solidifying it to form a solid pellet. The resulting tablet disintegrates rapidly, allowing for efficient absorption by the patient.
The second patent, "Process to Form an Orally Disintegrating Tablet for Human Use," focuses on preparing orally disintegrating tablets for the treatment of human disorders. Similarly, this approach involves filling a cavity with a fluid formulation, followed by solidification and drying to obtain a tablet that disintegrates upon administration.
Career Highlights:
Hans Almer Middelbeek's impressive career includes contributions to renowned companies within the pharmaceutical industry. Notably, he has worked at Intervet B.V., an animal health company, and Intervet Inc., its subsidiary. His tenure at these organizations allowed him to contribute his inventive expertise to the development of innovative drug delivery systems and pharmaceutical formulations.
Collaborations:
Throughout his career, Hans Almer Middelbeek had the opportunity to collaborate with esteemed colleagues, further enhancing his inventive endeavors. Notably, he worked alongside Jozefus A C Smit and Rogier Biemans, whose expertise complemented his own. These collaborations fostered an environment of creativity and knowledge exchange, leading to remarkable advancements in pharmaceutical technology.
Conclusion:
Hans Almer Middelbeek's inventive contributions have significantly impacted the pharmaceutical industry, particularly in the development of tablet formulations that enhance drug delivery. His patents demonstrate his ability to think outside the box and devise innovative solutions to improve patient outcomes. Collaborating with top pharmaceutical companies and talented colleagues, Middelbeek's commitment to innovation continues to shape the industry. As we eagerly anticipate his future endeavors, it is clear that his contributions will pave the way for new advancements that benefit both patients and the pharmaceutical field as a whole.